Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)

Warfarin has been widely used to treat thromboembolism. The effect of nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH), on warfarin dosing remains unknown. This study aims to examine the effects of NAFLD/NASH on the average daily dose (ADD) of warfarin and the time in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Xuerong, Wang, Shuang, Taveira, Tracey H., Akhlaghi, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443040/
https://www.ncbi.nlm.nih.gov/pubmed/34525124
http://dx.doi.org/10.1371/journal.pone.0251665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443040/
https://www.ncbi.nlm.nih.gov/pubmed/34525124
http://dx.doi.org/10.1371/journal.pone.0251665

Ejemplares similares